Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomeres: prognostic markers for solid tumors.

Marco Bisoffi1, Christopher M Heaphy, Jeffrey K Griffith

  • 1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, Albuquerque, 87131-0001, USA.

International Journal of Cancer
|July 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcoma.

BMC cancer·2026
Same author

Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape.

Molecular cancer·2026
Same author

PGC-1α agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice.

Blood advances·2026
Same author

A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Distinct Malignant Cell States and Myeloid Glutamate Signaling Associated with Aggressive Pancreatic Neuroendocrine Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcoma.

bioRxiv : the preprint server for biology·2026

Telomeres, the protective DNA caps on chromosomes, show altered lengths during cancer development. Measuring telomere length can improve prognosis for solid tumors, aiding treatment decisions.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Solid tumors pose significant global health challenges, with current prognostic markers like the Tumor-Nodes-Metastasis (TNM) staging system showing limitations in predicting disease course.
  • The inaccuracy of existing markers leads to both overtreatment and undertreatment, impacting patient quality of life and the efficacy of cancer screening programs.

Purpose of the Study:

  • To review the utility of telomeres as independent prognostic markers for various solid tumors.
  • To explore how telomere length alterations correlate with cancer progression and patient outcomes.

Main Methods:

  • Review of existing scientific literature on telomere length dynamics in solid tumors.
  • Analysis of studies measuring telomere attrition and elongation in relation to clinical markers of disease progression.

Related Experiment Videos

Main Results:

  • Telomere length alterations (attrition and elongation) are observed during tumor initiation and progression.
  • In several studies, telomere length changes have been associated with clinical markers of disease progression.
  • Telomere length has demonstrated potential as an independent prognostic marker for solid tumors, including lung, breast, prostate, colon, brain, and head and neck cancers.

Conclusions:

  • Telomere length assessment, or evaluation of its proxies like telomere DNA content, shows promise for novel risk stratification in solid tumors.
  • Incorporating telomere analysis into prognostic modalities could lead to more personalized and effective cancer treatment strategies.